Concepedia

G. Dark

GD

18

Publications

1.9K

Citations

17

H-Index

1997

Active since

Affiliations

Beatson West of Scotland Cancer Centre(Current)

University College London

University of Birmingham

Clatterbridge Cancer Centre NHS Foundation Trust

Newcastle University

G. Dark is an author at Beatson West of Scotland Cancer Centre specializing in oncology, medicine, and cancer therapeutics.

Top concepts

Publications per year

1997–2022

18

Publications

18

Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.

G. Dark, S A Hill, Vivien E. Prise et al. · PubMed · 1997 · 624 citations

, , +16

Differentiation and Definition of Vascular-Targeted Therapies

Dietmar W. Siemann, Michael C. Bibby, G. Dark et al. · Clinical Cancer Research · 2005 · 267 citations · Full text

Proven bioequivalence of blood exposure between vinorelbine 80 mg/m<sup>2</sup> oral and 30 mg/m<sup>2</sup> IV doses in cancer patients

Hugues Bourgeois, Jan B. Vermorken, G. Dark et al. · Journal of Clinical Oncology · 2005 · 179 citations

, , +21

Surveillance policy for stage I ovarian germ cell tumors.

G. Dark, Mark Bower, E.S. Newlands et al. · Journal of Clinical Oncology · 1997 · 137 citations

Pemetrexed Combined with Oxaliplatin or Carboplatin as First-Line Treatment in Advanced Non–Small Cell Lung Cancer: A Multicenter, Randomized, Phase II Trial

Giorgio V. Scagliotti, C. Kortsik, G. Dark et al. · Clinical Cancer Research · 2005 · 137 citations · Full text

Rows per page

1–5 of 18